Duquesne University of the Holy Spirit Patent applications |
Patent application number | Title | Published |
20150193653 | Kinetic-based tool for biometric identification, verification, validation and profiling - A method for identifying an animal or human, including the steps of collecting and retaining an archive data set of measurements of two or more kinetic stylometrics of a first individual animal or human; collecting and retaining a test data set of measurements of the same two or more kinetic stylometrics of a test individual; and comparing archive and test data sets to determine similarity therefore, wherein similarity within any appropriate confidence interval confirms that the test individual and the first individual are the same. Using similar methods, social or other groups maybe kinetically stylometrically profiled for subsequent individual testing. | 07-09-2015 |
20150047037 | Computer Security System and Method - The present invention is a computer security system and method in which the various algorithms not only do not search for or detect the presence of a steganographic or other hidden image in a data file or across data files, but also includes at least one or more combined approaches for altering and neutralizing any hidden messages without significantly detracting from the underlying integrity of the data file or files thus treated. | 02-12-2015 |
20150046346 | Authorship Technologies - Novel distractorless authorship verification technology optionally combines with novel algorithms to solve authorship attribution as to an open set of candidates—such as without limitation by analyzing the voting of “mixture of experts” and outputting the result to a user using the following: if z (z=p | 02-12-2015 |
20140303188 | Substituted Cyclopenta Pyrimidine Bicyclic Compounds Having Antitmitotic And/Or Antitumor Activity And Methods Of Use Thereof - The present invention provides substituted cyclopenta and cyclopentyl pyrimidine bicyclic compounds of Formula III, | 10-09-2014 |
20140171396 | Combination Hormone Replacement Therapy (HRT) and Melatonin to Prevent and Treat Mammary Cancer - A combination hormone and melatonin therapy is provided to reduce the risk of developing, or to reduce the severity of, breast cancer by administering at least one estrogen hormone and optionally at least one progesterone-receptor-binding compound or composition and melatonin together, preferably at normal bed time. | 06-19-2014 |
20130072539 | Anti-Cancer Tamoxifen-Melatonin Hybrid Ligand - A particularly constructed tamoxifen-melatonin hybrid ligand gives new and unexpectedly improved results in the prevention and treatment of cancer, particularly breast cancer. The hybrid ligand comprises either tamoxifen or 4-hydroxy-tamoxifen and also melatonin, with the tamoxifen or 5-hydroxy-tamoxifen and melatonin's being linked by an unsubstituted C | 03-21-2013 |
20110117193 | ANTIRETROVIRAL DRUG FORMULATIONS FOR TREATMENT OF CHILDREN EXPOSED TO HIV/AIDS - The present disclosure provides fast disintegrating formulations for the treatment of human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) in patients such as neonatal, perinatal and pediatric children. Neonatal and perinatal formulations provide for the prevention or reduction of incidence of mother to child transmission of HIV. Also provided are formulations and methods for treating pediatric children having HIV/AIDS. The orally administered fast disintegrating formulations are in granule and tablet form and are specially formulation for children to increase adherence to treatment protocols. | 05-19-2011 |
20100041158 | Lead sensor and methods of use - A fluorophore that forms a complex with Pb ions is disclosed. The fluorophore/lead complex fluoresces with an intensity greater than complexes formed by the fluorophore with other metals. The fluorophore may be used as a sensor/detector for lead ions in various samples. Methods for detecting and calculating the concentration of lead ions in samples are also disclosed. | 02-18-2010 |
20090326224 | THIENO PYRIMIDINE COMPOUNDS - A compound for treating cancer tumors, particularly ovarian cancer tumors, is described, where a fused cyclic pyrimidine having a cancer treating ability is effective to allow selective delivery to a cancerous tumor. | 12-31-2009 |